Sarcoidosis following alemtuzumab treatment: Autoimmunity mediated by T cells and interferon-γ

Mult Scler. 2018 Nov;24(13):1783-1784. doi: 10.1177/1352458518804124. Epub 2018 Oct 11.

Author

Steffen Pfeuffer¹

Affiliation

¹ Department of Neurology with Institute of Translational Neurology, University of Muenster, Muenster, Germany.

PMID: 30307361
DOI: 10.1177/1352458518804124

No abstract available

Keywords: Alemtuzumab; immunology; treatment response.

Publication types

Review

MeSH terms

Alemtuzumab / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use
Autoimmunity / drug effects*
Humans
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Sarcoidosis / drug therapy*
T-Lymphocytes / drug effects*
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Alemtuzumab